Posted: Nov 17, 2017
"Where else can you make such a profound difference not only for the individual now, but for those who come in the future? It is hard work, good work and worth doing well.” Physician Assistant Julia Friend answers our questions about why she loves working for CCR. Read more...
Posted: Oct 26, 2017
Decades ago, the use of chimeric antigen receptor (CAR)-expressing T cells as an effective form of immunotherapy was a speculative idea. In 2010, a breakthrough clinical trial conducted by Steven Rosenberg, M.D., Ph.D., and his clinical team showed that CAR T cells recognizing the CD19 receptor were useful in the treatment of some types of B-cell malignancies. Read more...
Posted: Oct 17, 2017
Daniel Webster, Ph.D., a former fellow at CCR, has been named a 2017 STAT Wunderkind for the development of “Mole Mapper” — an app that catalogs potentially cancerous moles and helps those at risk of skin cancer effectively communicate with researchers and clinicians. STAT News, a publication produced by Boston Globe Media, annually selects 26 young scientists as “wunderkinds” in recognition of their efforts to answer some of the biggest questions in medicine. According to STAT, “Over the past several months, a team of STAT editors and reporters pored through nearly 300 nominations from across North America. We didn’t set an age limit; we were on the hunt for the most impressive doctors and researchers on the cusp of launching their careers but not yet fully independent. Most were postdocs, fellows, and biopharma employees working with more senior scientists.” Dr. Webster currently works at Sage Bionetworks.
Posted: Oct 3, 2017
National Postdoc Appreciation Week took place Sept. 18-22, 2017, and the Center for Cancer Research (CCR) joined in to celebrate the work of our postdocs. The CCR offers basic and translational research opportunities for pre- and postdoctoral fellows with competitive stipends through the Cancer Research Training Award. Throughout the week, our postdocs shared their reasons for choosing CCR, and we highlighted some of our outstanding postdocs and why CCR is a premier training institution. To get a glimpse into why these postdocs chose CCR for their training, check out this Storify...
Posted: Sep 27, 2017
On September 20, 2017, the National Cancer Institute co-hosted a Twitter chat with the Lymphoma Research Foundation for Blood Cancer Awareness and Childhood Cancer Awareness Month. Nirali Shah, M.D., of the Center for Cancer Research, and Nita Seibel, M.D., of the Division of Cancer Treatment and Diagnosis, offered their expertise to discuss lymphoma treatment and trials for children and young adults. This Storify recaps the Twitter chat.
Douglas Lowy and Nirali Shah discuss advancements in cancer treatment at the second annual Chasing Cancer Summit
Posted: Sep 26, 2017
On Monday, September 18, 2017, the second annual Chasing Cancer Summit was held at the Washington Post headquarters in downtown Washington, D.C. The live event brought together a group of experts, including CCR’s Douglas Lowy, M.D., and Nirali Shah, M.D., for discussions on the latest developments in cancer detection and treatment. Read more...
Posted: Aug 18, 2017
Believe it or not, camp was a favorite part of summer for Nesma Aly from 2008 to 2016. When Nesma was nine months old she was diagnosed with osteopetrosis, a rare congenital disorder in which bones become prone to break easily due to an imbalance in bone formation and breakdown. Camp Fantastic is distinctive in that it provides a normal camping experience for a unique group: children between the ages of 7 and 19 who are undergoing cancer treatment presently or in the last three years, or a bone marrow transplant in the last five years. The 2017 Camp Fantastic session runs August 13-19. Read more...
Posted: Aug 17, 2017
Leading up to the premiere of the three-part documentary, First in Human, Discovery hosted a Twitter chat on Wednesday, August 9, 2017, to discuss clinical trials and the making of the film. Stephanie Goff, M.D., Staff Clinician in the Surgery Branch, and Terry Fry, M.D., Investigator in the Pediatric Oncology Branch, represented the Center for Cancer Research in the chat. This Storify post recaps the chat and gives the audience an inside look at the making of the documentary.